• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群衍生的氧化三甲胺:膳食脂肪酸与心血管疾病之间的桥梁?

Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?

作者信息

He Mengxue, Tan Chin-Ping, Xu Yong-Jiang, Liu Yuanfa

机构信息

State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food, National Engineering Laboratory for Cereal Fermentation Technology, Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, China.

Department of Food Technology, Faculty of Food Science and Technology, Universiti Putra Malaysia, Malaysia.

出版信息

Food Res Int. 2020 Dec;138(Pt B):109812. doi: 10.1016/j.foodres.2020.109812. Epub 2020 Oct 21.

DOI:10.1016/j.foodres.2020.109812
PMID:33288187
Abstract

Cardiovascular disease (CVD) is a serious disease that endangers human health and is one of the leading causes of death. Recent studies have reported that gut microbiota plays an important role in the development of CVD, especially its metabolite trimethylamine-N-oxide (TMAO). Dietary precursors, such as choline, L-carnitine, phosphatidylcholine and betaine were metabolized to trimethylamine (TMA) under the action of gut microbiota, and subsequently oxidized by hepatic flavin monooxygenases (FMOs) to form TMAO. Dietary fat is one of three major nutrients in food, has been found to have a positive or negative effect on the development of CVD. Multiple clinical and experimental evidences suggested that dietary fatty acids (FAs) can affect TMAO production through gut microbiota and/or FMO3 enzyme activity. This article summarizes the existing gut microbiota-mediated reduction of TMA, discusses the molecular mechanism of dietary FAs in the pathobiology of CVD from the view of TMAO. Therefore, this review provides new insight into the association of dietary FAs and CVD, paving the way for dietary FAs therapy for CVD.

摘要

心血管疾病(CVD)是一种严重危害人类健康的疾病,是主要死因之一。最近的研究报道,肠道微生物群在心血管疾病的发展中起重要作用,尤其是其代谢产物氧化三甲胺(TMAO)。膳食前体,如胆碱、左旋肉碱、磷脂酰胆碱和甜菜碱,在肠道微生物群的作用下代谢为三甲胺(TMA),随后被肝脏黄素单加氧酶(FMOs)氧化形成TMAO。膳食脂肪是食物中的三大主要营养素之一,已发现其对心血管疾病的发展有正面或负面影响。多项临床和实验证据表明,膳食脂肪酸(FAs)可通过肠道微生物群和/或FMO3酶活性影响TMAO的产生。本文总结了现有的肠道微生物群介导的TMA还原,从TMAO的角度探讨了膳食脂肪酸在心血管疾病病理生物学中的分子机制。因此,本综述为膳食脂肪酸与心血管疾病的关联提供了新的见解,为心血管疾病的膳食脂肪酸治疗铺平了道路。

相似文献

1
Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?肠道微生物群衍生的氧化三甲胺:膳食脂肪酸与心血管疾病之间的桥梁?
Food Res Int. 2020 Dec;138(Pt B):109812. doi: 10.1016/j.foodres.2020.109812. Epub 2020 Oct 21.
2
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶,可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
3
Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?饮食可以调节三甲胺 N-氧化物(TMAO)的产生吗?目前我们了解多少?
Eur J Nutr. 2021 Oct;60(7):3567-3584. doi: 10.1007/s00394-021-02491-6. Epub 2021 Feb 3.
4
Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.饮食因素、肠道微生物群和血清三甲胺 N-氧化物与西班牙裔社区健康研究/拉丁裔研究中的心血管疾病相关。
Am J Clin Nutr. 2021 Jun 1;113(6):1503-1514. doi: 10.1093/ajcn/nqab001.
5
Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice.膳食胆碱、甜菜碱和左旋肉碱对健康小鼠体内 trimethylamine-N-oxide 生成的影响。
J Food Sci. 2020 Jul;85(7):2207-2215. doi: 10.1111/1750-3841.15186. Epub 2020 Jun 22.
6
Trimethylamine N-Oxide as a Potential Biomarker for Cardiovascular Disease: Its Association with Dietary Sources of Trimethylamine N-Oxide and Microbiota.氧化三甲胺作为心血管疾病的潜在生物标志物:其与氧化三甲胺饮食来源及微生物群的关联
Eurasian J Med. 2023 Oct;55(1):S21-S26. doi: 10.5152/eurasianjmed.2023.23070.
7
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
8
Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function.三甲基胺氧化物:饮食、肠道微生物群、肝脏和肠道胆固醇稳态及高密度脂蛋白功能的基因调控之间的联系。
Int J Mol Sci. 2018 Oct 19;19(10):3228. doi: 10.3390/ijms19103228.
9
Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.调节肠道微生物群衍生代谢物氧化三甲胺的膳食生物活性成分。功能性食品开发的新机遇。
Food Funct. 2020 Aug 1;11(8):6745-6776. doi: 10.1039/d0fo01237h. Epub 2020 Jul 20.
10
The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.采用体外批量发酵(人体结肠)模型研究人体肠道微生物群从胆碱、左旋肉碱和相关前体产生 TMA 的机制。
Eur J Nutr. 2021 Oct;60(7):3987-3999. doi: 10.1007/s00394-021-02572-6. Epub 2021 May 2.

引用本文的文献

1
Associations between dietary index for gut microbiota with COPD prevalence and all-cause mortality: insights from the 1999-2018 NHANES data.肠道微生物群饮食指数与慢性阻塞性肺疾病患病率及全因死亡率之间的关联:来自1999 - 2018年美国国家健康与营养检查调查数据的见解
BMC Pulm Med. 2025 Sep 1;25(1):417. doi: 10.1186/s12890-025-03908-2.
2
Exploring the trimethylamine-degrading genes in the human gut microbiome.探索人类肠道微生物群中三甲胺降解基因。
AMB Express. 2025 Jun 12;15(1):91. doi: 10.1186/s13568-025-01902-9.
3
TMAO promotes metabolic dysfunction-associated fatty liver disease (MAFLD) development through long-non coding RNA- highly upregulated liver cancer (HULC).
氧化三甲胺通过长链非编码RNA-高表达肝癌(HULC)促进代谢功能障碍相关脂肪性肝病(MAFLD)的发展。
J Diabetes Metab Disord. 2025 May 30;24(1):131. doi: 10.1007/s40200-025-01605-9. eCollection 2025 Jun.
4
Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis.肠道微生物群在慢性肝病发生发展中的作用:肠道微生物群-肝脏轴
World J Hepatol. 2025 Mar 27;17(3):104167. doi: 10.4254/wjh.v17.i3.104167.
5
Role of Trimethylamine N-Oxide in Heart Failure.氧化三甲胺在心力衰竭中的作用。
Rev Cardiovasc Med. 2024 Jul 2;25(7):240. doi: 10.31083/j.rcm2507240. eCollection 2024 Jul.
6
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease.肠-肝轴和胰高血糖素样肽-1 受体激动剂在代谢功能障碍相关脂肪性肝病治疗中的作用。
World J Gastroenterol. 2024 Jun 21;30(23):2964-2980. doi: 10.3748/wjg.v30.i23.2964.
7
Effects of Saponins on Lipid Metabolism: The Gut-Liver Axis Plays a Key Role.皂苷对脂代谢的影响:肠-肝轴起着关键作用。
Nutrients. 2024 May 17;16(10):1514. doi: 10.3390/nu16101514.
8
Gut microbiota connects the brain and the heart: potential mechanisms and clinical implications.肠道微生物群连接大脑和心脏:潜在机制和临床意义。
Psychopharmacology (Berl). 2024 Apr;241(4):637-651. doi: 10.1007/s00213-024-06552-6. Epub 2024 Feb 26.
9
Effects of alcohol on the composition and metabolism of the intestinal microbiota among people with HIV: A cross-sectional study.HIV 感染者肠道菌群的组成和代谢受酒精影响:一项横断面研究。
Alcohol. 2024 Nov;120:151-159. doi: 10.1016/j.alcohol.2024.02.003. Epub 2024 Feb 20.
10
A normative microbiome is not restored following kidney transplantation.肾脏移植后无法恢复正常的微生物组。
Clin Sci (Lond). 2023 Oct 31;137(20):1563-1575. doi: 10.1042/CS20230779.